RankAlpha logo
Back to Rankings

LYEL

Lyell ImmunopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LYEL vs peer average
26/100
LYEL vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

FENC is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $346.68M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerFENCFennec
LYEL
Lyell Immunopharma
FENC
Fennec
Grade
F
A
Momentum
5
96
Value
41
42
Sentiment
-
99
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs FENC

LYEL / FENC
Grade Position
Below peers
LYEL vs. peer average (F vs. C)
26/100
Momentum
5
FENC
Value
41
FENC
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LYEL
1
FENC
Fennec Pharmaceuticals Inc Common
A
100/100
-4
2
ENTA
Enanta Pharmaceuticals Inc Common
F
20/100
Even
3
LRMR
Larimar Therapeutics Inc Common
D
40/100
-1
4
AVIR
Atea Pharmaceuticals Inc Common
F
20/100
Even
5
LXEO
Lexeo Therapeutics Inc Common
F
20/100
Even
FENC is the first peer returned for this comparison set.